ATE378426T1 - Neue sequenz um die expression einer nukleinsäure zu erhöhen - Google Patents

Neue sequenz um die expression einer nukleinsäure zu erhöhen

Info

Publication number
ATE378426T1
ATE378426T1 AT05756870T AT05756870T ATE378426T1 AT E378426 T1 ATE378426 T1 AT E378426T1 AT 05756870 T AT05756870 T AT 05756870T AT 05756870 T AT05756870 T AT 05756870T AT E378426 T1 ATE378426 T1 AT E378426T1
Authority
AT
Austria
Prior art keywords
expression
nucleic acid
increase
new sequence
repressor
Prior art date
Application number
AT05756870T
Other languages
German (de)
English (en)
Inventor
Arie Otte
Theodorus Kwaks
Richard George Antonius Sewalt
Blokland Henricus Johannes Van
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE378426(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Application granted granted Critical
Publication of ATE378426T1 publication Critical patent/ATE378426T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05756870T 2004-07-08 2005-07-07 Neue sequenz um die expression einer nukleinsäure zu erhöhen ATE378426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58700704P 2004-07-08 2004-07-08
EP2004051405 2004-07-08

Publications (1)

Publication Number Publication Date
ATE378426T1 true ATE378426T1 (de) 2007-11-15

Family

ID=34971366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05756870T ATE378426T1 (de) 2004-07-08 2005-07-07 Neue sequenz um die expression einer nukleinsäure zu erhöhen

Country Status (19)

Country Link
US (1) US7825232B2 (https=)
JP (1) JP4805262B2 (https=)
KR (1) KR101188013B1 (https=)
CN (1) CN1981057B (https=)
AT (1) ATE378426T1 (https=)
AU (1) AU2005261699B2 (https=)
BR (1) BRPI0512798A (https=)
CA (1) CA2573022C (https=)
DE (1) DE602005003369T2 (https=)
DK (1) DK1763586T3 (https=)
EA (1) EA011747B1 (https=)
ES (1) ES2296201T3 (https=)
IL (1) IL180531A (https=)
MX (1) MXPA06014553A (https=)
NO (1) NO341862B1 (https=)
NZ (1) NZ551510A (https=)
PT (1) PT1763586E (https=)
WO (1) WO2006005718A2 (https=)
ZA (1) ZA200610470B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354645T1 (de) * 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
ES2384391T3 (es) 2004-11-08 2012-07-04 Chromagenics B.V. Selección de células hospedantes que expresan proteína a altos niveles
KR101271884B1 (ko) * 2004-11-08 2013-06-05 크로마제닉스 비.브이. 고수준으로 단백질을 발현하는 숙주세포의 선택
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
EP2443239B1 (en) 2009-06-15 2015-11-25 Cellagenics B.V. Novel stringent selectable markers
WO2011159157A1 (en) 2010-06-15 2011-12-22 Cellagenics B.V. Novel intergenic elements for enhancing gene expression
DK2611915T3 (da) 2010-09-01 2015-06-22 Cellagenics B V Nukleinsyrefragmenter fra en ribosomal proteinpromoter til forstærkning af genekspression
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1600510E (pt) * 2001-07-04 2007-06-25 Chromagenics Bv Sequências de adn com actividade anti-repressora.
CA2489475C (en) 2002-06-14 2011-03-29 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
ATE354645T1 (de) * 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können

Also Published As

Publication number Publication date
AU2005261699B2 (en) 2009-07-23
MXPA06014553A (es) 2007-03-12
HK1097004A1 (en) 2007-06-15
CA2573022C (en) 2012-03-06
PT1763586E (pt) 2008-02-25
JP2008505626A (ja) 2008-02-28
KR20070042122A (ko) 2007-04-20
BRPI0512798A (pt) 2008-04-08
DE602005003369D1 (de) 2007-12-27
CN1981057A (zh) 2007-06-13
EA011747B1 (ru) 2009-06-30
AU2005261699A1 (en) 2006-01-19
EA200700233A1 (ru) 2007-06-29
CN1981057B (zh) 2012-07-04
NO341862B1 (no) 2018-02-12
US20070212755A1 (en) 2007-09-13
ES2296201T3 (es) 2008-04-16
US7825232B2 (en) 2010-11-02
DK1763586T3 (da) 2008-03-17
KR101188013B1 (ko) 2012-10-08
CA2573022A1 (en) 2006-01-19
DE602005003369T2 (de) 2009-03-05
IL180531A0 (en) 2007-06-03
WO2006005718A3 (en) 2006-08-17
NZ551510A (en) 2009-10-30
WO2006005718A2 (en) 2006-01-19
IL180531A (en) 2011-04-28
JP4805262B2 (ja) 2011-11-02
NO20070757L (no) 2007-02-08
ZA200610470B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
NO20042570L (no) Antimikrobielle polypeptider fra Pseudoplectania nigrella
DK1836299T4 (da) Polypeptider, der har cellobiohydrolaseaktivitet, og polynukleotider, der koder for disse
WO2006039541A3 (en) Polypeptides having lipase activity and polynucleotides encoding same
DK1578964T3 (da) Polypeptider med cellobiohydrolase II-aktivitet og polynukleotider, der koder for samme
CR9969A (es) Anticuerpos anti-globulomero ab, porciones de union a antigeno de estos, hibridomas correspondientes, acidos nucleicos, vectores, celulas huesped, metodos para producir dichos anticuerpos, composiciones que comprenden dichos anticuerpos
DE60042775D1 (de) Verbesserte sequenzierung mittels hybridisierung durch verwendung von sondengemischen
DE60139542D1 (de) Methoden zur herstellung humaner monoklonaler antikörper
DK1831362T3 (da) Syreaktive svampeproteaser
NO20062117L (no) Multispesifikke deimmuniserte CD3-bindere
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
EP1692255A4 (en) EXTRACTION OF NUCLEIC ACID FROM EPITHELIAL CELLS FROM THE MOUTH
WO2006047469A8 (en) Polypeptides having lipase activity and polynucleotides encoding same
ATE407939T1 (de) 2ß-NITROBENZYL-MODIFIZIERTE RIBONUKLEOTIDE
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
ATE463572T1 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
ATE513041T1 (de) Ghrelin bindende nukleinsäuren
DE602005017034D1 (de) Signalpeptid zur herstellung eines polypeptids
DK1963514T3 (da) Fremgangsmåder til fototransferering af nukleinsyre til levende celler
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
DK1208213T3 (da) Fremgangsmåde til fremstilling af proteiner i værtsceller under anvendelse af chaperoniner
ATE414905T1 (de) Diabetesmodell
EA200702009A1 (ru) Усовершенствованный способ экспрессирующего клонирования в клетке-хозяине
BRPI0411248A (pt) método para produzir um polipeptìdeo
WO2005017112A3 (en) Methods of inhibiting cancer growth by binding to nuclear receptors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1763586

Country of ref document: EP